1. Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951.
2. Srivastava P, Gupta N. Clinical manifestations of corona virus disease. Clinical Synopsis of COVID-19: Evolving and Challenging. 2020:31-49.
3. van der Made CI, Netea MG, van der Veerdonk FL, Hoischen A. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19. Genome Med. 2022;14(1):96.
4. Kak G, Raza M, Tiwari BK. Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases. Biomol Concepts. 2018;9(1):64-79.
5. Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53(14):25-32.
6. Xu H, Li W, Fu H, Jiang G. Interferon-gamma gene polymorphism+ 874 (A/T) in Chinese children with Henoch-Schönleinpurpura. Iran J Allergy Asthma Immunol. 2014:184-9.
7. Zhang Y, Qin L, Zhao Y, Zhang P, Xu B, Li K, et al. Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019. J Infect Dis. 2020;222(1):34-7.
8.Farhat K, Hassen E, Gabbouj S, Bouaouina N, Chouchane L. Interleukin‐10 and interferon‐gamma gene polymorphisms in patients with nasopharyngeal carcinoma. Int J Immunogenetics. 2008;35(3):197-205.
9. Ivashkiv LB. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18(9):545-58.
10. Sarges KM, Póvoa da Costa F, Santos EF, Cantanhede MH, da Silva R, et al. Association of the IFNG+ 874T/A Polymorphism with Symptomatic COVID-19 Susceptibility. Viruses. 2024;16(4):650.
11. Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ. Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Fron Immunol. 2018;9(3):847.
12. Teker E, Akadam-Teker AB, Ozturk O, Eronat AP, Yalin K, Golcuk SE, et al. Association between the interferon gamma 874 T/A polymorphism and the severity of valvular damage in patients with rheumatic heart disease. Biochem Genetics. 2018;56(12):225-34.
13. Vu D, Shah T, Ansari J, Sakharkar P, Yasir Q, Naraghi R, Hutchinson I, Min D. Interferon‐gamma gene polymorphism+ 874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients. Trans Infect Dis. 2014;16(5):724-32.
14. Dieter C, Brondani LD, Leitão CB, Gerchman F, Lemos NE, Crispim D. Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis. PLoS One. 2022;17(7):e0270627.